Slide 11 Post-Marketing Surveillance: Passive and Active Approaches and Use of Electronic Databases Karen Midthun, MD, Deputy Director Center for Biologics Evaluation and…

Slide 1 Threats and constraints | Onderstepoort Biological Products © |22nd February 2013Page 31 Negative perception – OBP Brand (RVF) Product availability-equipment break…

Slide 1 Elaine R. Miller, RN, MPH Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers…

Slide 1 The Regulation of Human Drugs FSC-421 Slide 2 What is a Drug? Slide 3 Section 201 (G) (A) Aricles recognized in Official Pharmacoepia (B) Articles intended for use…

Risky Business: Talking to Parents about Vaccines NC Immunization Conference August 2011 Kristina Simeonsson, MD, MSPH Karin Hillenbrand, MD The Brody School of Medicine…

Communicating Effectively About Vaccines: New Communication Resources for Health Officials Communicating Effectively About Vaccines 2 © 2010 Association of State and Territorial…

Vaccines Overview Vaccine production methods Vaccine types and Diseases preventable by vaccines Vaccine modifications Routes of administration Reverse vaccinology Safety…

Slide 1 The Vaccine Debate Mentor 912 Group, 6/5/13 Vaccine Debate Purpose of presentation: To present evidence that further questions are warranted on the safety of vaccines.…

Johns Hopkins Vaccine Initiative JHVIâs Mission The mission of the Johns Hopkins Vaccine Initiative is to promote collaborative and interdisciplinary vaccine research, education,…